258 related articles for article (PubMed ID: 32367178)
1. Outcomes related to intravenous fluid administration in sickle cell patients during vaso-occlusive crisis.
Gaut D; Jones J; Chen C; Ghafouri S; Leng M; Quinn R
Ann Hematol; 2020 Jun; 99(6):1217-1223. PubMed ID: 32367178
[TBL] [Abstract][Full Text] [Related]
2. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
Okomo U; Meremikwu MM
Cochrane Database Syst Rev; 2015 Mar; (3):CD005406. PubMed ID: 25764071
[TBL] [Abstract][Full Text] [Related]
3. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
Okomo U; Meremikwu MM
Cochrane Database Syst Rev; 2012 Jun; (6):CD005406. PubMed ID: 22696351
[TBL] [Abstract][Full Text] [Related]
4. Intravenous fluid therapy and hospital outcomes for vaso-occlusive episodes in children, adolescents, and young adults with sickle cell disease.
Haimed A; Weiss R; Kwon S; Bhat R; Badawy SM
Pediatr Blood Cancer; 2024 Feb; 71(2):e30781. PubMed ID: 38015105
[TBL] [Abstract][Full Text] [Related]
5. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
Okomo U; Meremikwu MM
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD005406. PubMed ID: 28759112
[TBL] [Abstract][Full Text] [Related]
6. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
Okomo U; Meremikwu MM
Cochrane Database Syst Rev; 2007 Apr; (2):CD005406. PubMed ID: 17443589
[TBL] [Abstract][Full Text] [Related]
7. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
[TBL] [Abstract][Full Text] [Related]
8. Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.
Gaartman AE; Sayedi AK; Gerritsma JJ; de Back TR; van Tuijn CF; Tang MW; Heijboer H; de Heer K; Biemond BJ; Nur E
Br J Haematol; 2021 Sep; 194(5):899-907. PubMed ID: 34263922
[TBL] [Abstract][Full Text] [Related]
9. Intravenous Hydration and Associated Outcomes in Patients With Sickle Cell Disease Admitted With Vaso-Occlusive Crises: A Systematic Review.
Pandey S; Tan EFS; Bellamkonda A; Aryal B; Karki S; Boddu G; Sapkota R; Changela M; Kalavar M
Cureus; 2024 Feb; 16(2):e54463. PubMed ID: 38510863
[TBL] [Abstract][Full Text] [Related]
10. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G
CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
[TBL] [Abstract][Full Text] [Related]
11. Sickle Cell Disease in the Emergency Department.
Lovett PB; Sule HP; Lopez BL
Hematol Oncol Clin North Am; 2017 Dec; 31(6):1061-1079. PubMed ID: 29078924
[TBL] [Abstract][Full Text] [Related]
12. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.
Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B
EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264
[TBL] [Abstract][Full Text] [Related]
13. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
[TBL] [Abstract][Full Text] [Related]
14. Magnesium for treating sickle cell disease.
Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830
[TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.
Morris CR; Kuypers FA; Lavrisha L; Ansari M; Sweeters N; Stewart M; Gildengorin G; Neumayr L; Vichinsky EP
Haematologica; 2013 Sep; 98(9):1375-82. PubMed ID: 23645695
[TBL] [Abstract][Full Text] [Related]
16. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
[TBL] [Abstract][Full Text] [Related]
17. Sickle cell disease in the emergency department.
Lovett PB; Sule HP; Lopez BL
Emerg Med Clin North Am; 2014 Aug; 32(3):629-47. PubMed ID: 25060254
[TBL] [Abstract][Full Text] [Related]
18. An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
Bulgin D; Bonnabeau E; Alexander A; Frederick E; Rains G; Shah N; Young M; Tanabe P
J Emerg Nurs; 2021 Jan; 47(1):40-49.e1. PubMed ID: 32826064
[TBL] [Abstract][Full Text] [Related]
19. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
20. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
